Boston Partners Care Dx, Inc. Transaction History
Boston Partners
- $77.6 Billion
- Q4 2024
A detailed history of Boston Partners transactions in Care Dx, Inc. stock. As of the latest transaction made, Boston Partners holds 21,299 shares of CDNA stock, worth $474,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,299
Previous 375,138
94.32%
Holding current value
$474,754
Previous $11.7 Million
96.11%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CDNA
# of Institutions
217Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$59.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$53.7 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$49.2 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.19B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...